Literature DB >> 9570547

Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells.

D M Ojcius1, Y Bravo de Alba, J M Kanellopoulos, R A Hawkins, K A Kelly, R G Rank, A Dautry-Varsat.   

Abstract

Chlamydia species are the causative agents of trachoma, various forms of pneumonia, and the most common sexually transmitted diseases. Although the infection cycle has been extensively characterized in epithelial cells, where the Chlamydia entry-vacuoles avoid fusion with host-cell lysosomes, the cellular immune response has received less attention. Moreover, despite the abundant presence of dendritic cells (DC) in the sites of infection, the interaction between Chlamydia and DC has never been studied. We observe that DC kill Chlamydia trachomatis and Chlamydia psittaci. The chlamydiae are internalized by the DC in a nonspecific manner through macropinocytosis, and the macropinosomes fuse subsequently with DC lysosomes expressing MHC class II molecules. The interaction induces maturation of the DC, since presentation of an exogenous Ag is severely inhibited after a 1-day incubation, although chlamydial Ags are still presented and recognized by Chlamydia-specific CD4+ T cells. Thus, DC most likely play a role in initiating the T cell response in vivo and could potentially be used in adoptive transfer therapies to vaccinate against Chlamydia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570547

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Dendritic cells: immune saviors or Achilles' heel?

Authors:  C W Cutler; R Jotwani; B Pulendran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C.

Authors:  M Amyere; B Payrastre; U Krause; P Van Der Smissen; A Veithen; P J Courtoy
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

3.  The intercellular adhesion molecule type-1 is required for rapid activation of T helper type 1 lymphocytes that control early acute phase of genital chlamydial infection in mice.

Authors:  J U Igietseme; G A Ananaba; J Bolier; S Bowers; T Moore; T Belay; D Lyn; C M Black
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

4.  Binding and internalization of Clostridium botulinum C2 toxin.

Authors:  Masahiro Nagahama; Tohko Hagiyama; Takashi Kojima; Kouhei Aoyanagi; Chihiro Takahashi; Masataka Oda; Yoshihiko Sakaguchi; Keiji Oguma; Jun Sakurai
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

5.  Interaction of Mycobacterium avium with human monocyte-derived dendritic cells.

Authors:  N Mohagheghpour; A van Vollenhoven; J Goodman; L E Bermudez
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis.

Authors:  Elisabeth Billard; Chantal Cazevieille; Jacques Dornand; Antoine Gross
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Fate of Mycobacterium tuberculosis within murine dendritic cells.

Authors:  K A Bodnar; N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 8.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

9.  Sequential activities of phosphoinositide 3-kinase, PKB/Aakt, and Rab7 during macropinosome formation in Dictyostelium.

Authors:  A Rupper; K Lee; D Knecht; J Cardelli
Journal:  Mol Biol Cell       Date:  2001-09       Impact factor: 4.138

10.  Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis.

Authors:  V Maréchal; M C Prevost; C Petit; E Perret; J M Heard; O Schwartz
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.